Newest studies
Every summary in our library, newest first, as a dated timeline.
Showing 776–800 of 27,380 studies, newest first · page 32 of 1096.
August 2026 25
-
2026-08-10
Rhabdomyolysis Secondary to Reactivated Herpes Simplex Virus Type 1 Coinfected with Klebsiella pneumoniae in an Elderly Patient: A Case Report
16/100 ⚠ Preprint — not yet peer-reviewed Prevention and risk Research Square
Key finding: After targeted anti-infection therapy, sufficient fluid resuscitation combined with nutritional and immune supportive care, the patient’s creatine kinase and inflammatory biomarkers normalized, and clinical status improved gradually. +4 more findings
Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.
Full summary, score breakdown and related studies → Original source
-
2026-08-10
Treatment of obstructive sleep apnea may contribute to long-term stabilisation of memory in Alzheimer's and vascular dementia
16/100 ⚠ Preprint — not yet peer-reviewed Risk factors Research Square
Key finding: Controlling for baseline differences, treatment of OSA improved delayed recall and may reduce the slope of memory decline in Alzheimer’s disease and vascular dementia. +2 more findings
Scored 42 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.
Full summary, score breakdown and related studies → Original source
-
2026-08-10
Cognitive Stimulation and Training in People with Mild-to-Moderate Alzheimer’s Disease: A Scoping Review
16/100 ⚠ Preprint — not yet peer-reviewed Cognitive tests and assessment Preprints.org
Key finding: Of 352 records identified, five studies involving 245 participants were included. +4 more findings
Scored 29 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.
Full summary, score breakdown and related studies → Original source
-
2026-08-10
A New Frontier in CWD Detection: Antemortem Plasma Biomarkers and Behavioral Profiling in Transgenic Mouse Models
16/100 ⚠ Preprint — not yet peer-reviewed Biomarkers bioRxiv
Key finding: Analyses at 90, 132, 174, and 230 days post-CWD inoculation show distinct biomarker elevation, with all three biomarkers significantly elevated in the CWD animals by 132 days post-inoculation. +1 more finding
Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.
Full summary, score breakdown and related studies → Original source
-
2026-08-10
Social isolation, loneliness, and blood-based AD/ADRD biomarkers in a nationally-representative study of middle-aged and older adults
16/100 ⚠ Preprint — not yet peer-reviewed Biomarkers medRxiv
Key finding: Social isolation was associated with elevated blood-based biomarkers of neuronal injury, with variation by patterns of exposure over time. +4 more findings
Scored 31 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.
Full summary, score breakdown and related studies → Original source
-
2026-08-10
Palliative care documentation in gastrointestinal bleeding hospitalizations: national trends and associated care patterns
41/100 ✓ Peer-reviewed End-of-life care Baylor University Medical Center Proceedings
Key finding: Among 2,435,099 weighted hospitalizations, palliative care documentation was present in 65,675 (2.70%), increasing from 2.13% in 2016 to 3.43% in 2022. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2026-08-10
Plasma Biomarkers for Neocortical Tau Burden
55/100 ✓ Peer-reviewed Biomarkers JAMA Neurology
Key finding: The study included 560 amyloid-positive participants (BioFINDER: n = 431; mean [SD] age, 73.6 [7.0] years; 212 female [49.2%] and 219 male [51.8%]; TRIAD: n = 129; mean [SD] age, 70.4 [8.3] years; 76 female [58.9%] and 53 male [41.1%]). +4 more findings
Full summary, score breakdown and related studies → Original source
-
2026-08-10
Social and socioeconomic factors and cognitive outcomes in multiple sclerosis
42/100 ✓ Peer-reviewed Risk factors Multiple Sclerosis and Related Disorders
Key finding: Non-White race and adverse social and socioeconomic factors-lower education, unemployment, unmarried status, and greater neighborhood disadvantage-were each associated with poorer cognitive performance (p < 0.05). +3 more findings
Full summary, score breakdown and related studies → Original source
-
2026-08-08
Stress-Specific Mitochondrial Reserve as a Candidate Modifier of Lipid-Driven Synaptic Failure in Alzheimer Disease
66/100 ✓ Peer-reviewed Treatments Zenodo (CERN European Organization for Nuclear Research)
Key finding: A recent randomized trial demonstrated clear cerebrospinal-fluid DHA target engagement without detectable improvement in cognition or brain volume over 24 months. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2026-08-08
Stress-Specific Mitochondrial Reserve as a Candidate Modifier of Lipid-Driven Synaptic Failure in Alzheimer Disease
45/100 ✓ Peer-reviewed Treatments Zenodo (CERN European Organization for Nuclear Research)
Key finding: A recent randomized trial demonstrated clear cerebrospinal-fluid DHA target engagement without detectable improvement in cognition or brain volume over 24 months. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2026-08-07
Sex-divergent trajectories of hippocampal and cortical NMDA receptor density across the Alzheimer’s disease continuum
16/100 ⚠ Preprint — not yet peer-reviewed Cognitive tests and assessment bioRxiv
Key finding: While loss of NMDA receptors (NMDARs) is associated with Alzheimer’s disease (AD) severity, the effect of sex or the relationship between regional NMDAR density and antemortem cognitive status across the AD spectrum has not been examined. +2 more findings
Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.
Full summary, score breakdown and related studies → Original source
-
2026-08-07
Conditional Latent Diffusion for Synthetic Brain MRI in Alzheimer’s Disease: A Preprocessing-Focused Pipeline
16/100 ⚠ Preprint — not yet peer-reviewed Digital health tools Preprints.org
Key finding: A classifier trained only on synthetic data achieved an area under the curve (AUC) of 0.754 (95% CI, 0.60 to 0.91), compared with 0.810 for real data.
Scored 32 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.
Full summary, score breakdown and related studies → Original source
-
2026-08-07
Gut Microbial Metabolism as a Dynamic Interface in Neurodegenerative Diseases
57/100 ✓ Peer-reviewed Disease mechanisms Metabolites
Key finding: SCFAs modulate epigenetic processes linked to Aβ and tau lesions. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2026-08-07
Relationships Among Hearing, Auditory Processing, and Cognition: A Study of Older Adults
41/100 ✓ Peer-reviewed Risk factors Audiology research
Key finding: DSI emerged as a significant predictor across both MoCA and CBB, surpassing the predictive power of both types of PTAs. +2 more findings
Full summary, score breakdown and related studies → Original source
-
2026-08-07
The effectiveness and safety of high-intensity interval training, yoga and intermittent hypoxia-hyperoxia exposure on cognitive performance and health in individuals with mild cognitive impairment (KAYH): a study protocol for a randomized, sham-controlled trial
16/100 ⚠ Preprint — not yet peer-reviewed Prevention trials medRxiv
Key finding: Individuals diagnosed with mild cognitive impairment (MCI) have an increased risk of developing dementia.
Scored 37 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.
Full summary, score breakdown and related studies → Original source
-
2026-08-07
Randomized metformin and cognitive outcomes in the Diabetes Prevention Program Outcomes Study
16/100 ⚠ Preprint — not yet peer-reviewed Drug development medRxiv
Key finding: Long-term metformin treatment is associated with a reduced risk of dementia and better memory performance among persons with pre-diabetes or T2D. Longer follow-up with more dementia cases is needed to confirm our findings. +4 more findings
Scored 55 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.
Full summary, score breakdown and related studies → Original source
-
2026-08-07
Mapping Amyloid-PET Uptake in the White Matter in Alzheimer’s Disease
16/100 ⚠ Preprint — not yet peer-reviewed Brain scans and imaging Research Square
Key finding: This study investigated whether WM measures derived from amyloid-PET are associated with AD biomarkers and to determine whether they offer added diagnostic and prognostic value beyond established biomarkers. +4 more findings
Scored 32 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.
Full summary, score breakdown and related studies → Original source
-
2026-08-07
Arterial Spin‐Labeling MRI at the Cortical‐ CSF Interface: A Novel Biomarker in Alzheimer Disease
41/100 ✓ Peer-reviewed Brain scans and imaging Annals of Clinical and Translational Neurology
Key finding: A total of 51 patients with AD, age (median: 73 years) and 53 cognitively normal subjects (median age: 69) were included. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2026-08-07
Sensitivity and specificity of the CANTAB Paired Associates Learning test for identifying mild cognitive impairment
37/100 ✓ Peer-reviewed Getting a diagnosis Acta Psychologica
Key finding: Although the small sample size may have influenced the results, the findings suggest that the PAL demonstrated good diagnostic accuracy for distinguishing participants with MoCA-defined MCI.
Full summary, score breakdown and related studies → Original source
-
2026-08-07
Clinical Practice Outcomes With Lecanemab for Alzheimer Disease
41/100 ✓ Peer-reviewed Treatments Neurology Open Access
Key finding: ε4 noncarriers and those with lower baseline amyloid burden. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2026-08-07
Plasma P-tau217 for detecting amyloid clearance after donanemab in Alzheimer's disease
54/100 ✓ Peer-reviewed Biomarkers Alzheimer's & Dementia
Key finding: Despite reductions in plasma p-tau217 with donanemab treatment, this biomarker cannot currently be used to accurately detect TRAC by PET (< 24.1 CL) in individuals with early symptomatic AD.
Full summary, score breakdown and related studies → Original source
-
2026-08-06
APP Dosage and Extracellular Domain Variants Drive Distinct Defects in Neurogenesis modeled in Down Syndrome iPS cells
16/100 ⚠ Preprint — not yet peer-reviewed Down syndrome and Alzheimer's bioRxiv
Key finding: Further analyses of the null and other mutant lines indicate that APP likely impacts these two distinct steps by two different mechanisms. +3 more findings
Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.
Full summary, score breakdown and related studies → Original source
-
2026-08-06
Diffusion MRI of Gray Matter Microstructural Profiles in Healthy Aging
57/100 ✓ Peer-reviewed Prevention trials Neuroscience and biobehavioral reviews
Key finding: This methodology has historically been applied only to white matter tissue in the research context, but more recent literature suggests that diffusion MRI can also be applied to study microstructural alterations of gray matter tissue, including in healthy aging.
Full summary, score breakdown and related studies → Original source
-
2026-08-06
Discovery of Natural Cholinesterase Inhibitors via Integrated Computational Studies using Labdane-Related Diterpenoids-based Pharmacophore Model and in-vitro studies
16/100 ⚠ Preprint — not yet peer-reviewed Treatments Research Square
Key finding: In recent years, labdane- related diterpenoids have attracted significant attention for their reported anticholinesterase efficacy, in tandem with their anti-inflammatory, antioxidant, and neuroprotective properties. +2 more findings
Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.
Full summary, score breakdown and related studies → Original source
-
2026-08-06
Semaglutide Activates the Orexin/Hypocretin and Basal Forebrain Cholinergic Systems and Increases Acetylcholine Levels in the Hippocampus of Young and Aged Rats
16/100 ⚠ Preprint — not yet peer-reviewed Drug development bioRxiv
Key finding: We found that the orexin/hypocretin and basal forebrain cholinergic systems are activated following acute semaglutide administration in male and female young adult rats (3-5 months). +1 more finding
Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.
Full summary, score breakdown and related studies → Original source
Browse the library by subject, with the full score breakdown →